Interferon gamma Antagonists [MoA] - N0000193855

Pharmacologic Code	N0000193855
Pharmacologic Name	Interferon gamma Antagonists
Pharmacologic Uses	interferon gamma (IFNγ) blocking antibody
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Interferon gamma Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	66658-501	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-505	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-510	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-522	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-523	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-524	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-525	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE